Probiotics Explained: Strains, CFUs, and What the Evidence Actually Supports

Probiotic labels are crowded with "billions of CFUs" and long lists of bacteria, yet the detail that matters most is the one most shoppers skip: the strain designation. This guide shows you how to read a probiotic label, where the research is genuinely strong, where it is mixed or missing, and who should avoid probiotics altogether.

What counts as a probiotic

The International Scientific Association for Probiotics and Prebiotics defines probiotics as "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host" [2]. They are mostly bacteria, but some are yeasts [1]. Not every fermented food or "contains live cultures" product meets that bar, and not every product labeled "probiotic" has proven benefits [1].

Several related terms often appear on the same shelf:

Why the strain matters more than the brand

Probiotics are identified by genus, species, subspecies (when there is one) and an alphanumeric strain designation [1]. Take Lacticaseibacillus rhamnosus GG, often shortened to LGG: Lacticaseibacillus is the genus, rhamnosus the species and GG the strain [1]. Another example is Bifidobacterium animalis subsp. lactis DN-173 010, where "lactis" is the subspecies [1].

This level of detail matters because some probiotic effects are shared broadly, while others belong to particular species or even individual strains. That is why expert bodies make strain-specific recommendations [1]. Evidence for one strain of L. rhamnosus tells you little about another.

Visitors, not residents

Most probiotics don't move into your gut permanently. Research summarized by the NIH indicates that they may colonize the gut lining only transiently, in highly individual patterns that depend on your existing microbiome, the strain and the section of the gut [1]. That helps explain why two people can respond quite differently to the same product.

The great Lactobacillus renaming

In 2020, microbiologists reorganized the old genus Lactobacillus into 25 genera, 23 of them newly named [3]. Some species kept the name (Lactobacillus acidophilus, for example) [3], while others moved. Lactobacillus rhamnosus is now Lacticaseibacillus rhamnosus [1]. Older studies and some labels still use the former names, so don't be thrown if the genus on your bottle doesn't match a paper from 2015.

Pro tip: Before buying, search the full strain designation (such as "GG") together with your health goal. If you can't find human trials for that strain, the product's claims are resting on borrowed evidence.

CFUs: what the number means and what it doesn't

Colony-forming units (CFUs) estimate how many viable cells a product contains. Many supplements provide 1 to 10 billion CFU per dose, and some provide 50 billion or more, but a higher count is not necessarily more effective [1].

Three labeling details are worth knowing:

• Weight versus CFU. U.S. regulations require only the total weight of the microorganisms, which can include dead cells. In a 2018 draft guidance, the FDA said it would allow companies to list CFUs alongside that weight [4], so a CFU number is voluntary but far more useful [1].
• Time of manufacture versus end of shelf life. Probiotics can die during storage, so look for CFU counts guaranteed through the end of shelf life, not at the time of manufacture [1].
• Storage. Some strains need refrigeration and others are shelf-stable; follow the label [1].

Label accuracy is a real concern. When researchers analyzed 16 probiotic products containing bifidobacteria, only one matched its label claims for bifidobacterial species in every sample tested, and contents varied from pill to pill and lot to lot [5].

Where the evidence is strongest: antibiotic-associated diarrhea

Antibiotics disrupt gut microbes, and up to 30% of people who take them develop antibiotic-associated diarrhea (AAD) [1]. This is the use with the most consistent research support.

• Children. A 2019 Cochrane review of 33 trials involving 6,352 children found AAD in 8% of those given probiotics versus 19% of controls, meaning about nine children needed treatment to prevent one case. Doses of at least 5 billion CFU per day were more effective (about six treated to prevent one case), and no serious adverse events were attributed to probiotics [6].
• Adults. In a meta-analysis summarized by the NIH, the probiotic yeast Saccharomyces boulardii cut AAD in adults from 17.4% to 8.2% [1]. Benefits have been seen in children and adults aged 18 to 64, but not in adults 65 and older [1].
• Timing. Starting within two days of the first antibiotic dose appears more effective than starting later [1]. A 2023 European pediatric position paper recommends LGG or S. boulardii at 5 billion CFU per day or more, started together with antibiotics, for children with risk factors for AAD [1, 8].

C. difficile: a small absolute benefit and split guidelines

Clostridioides difficile infection is a serious cause of antibiotic-related diarrhea. A 2025 Cochrane review (47 studies, 15,260 participants) found that probiotics may cut C. difficile diarrhea from 3.2% to 1.6%. That is a 50% relative reduction, but roughly 65 people would need probiotics to prevent one case, and the certainty of evidence was low. The authors also noted that 28 of the included studies had authors affiliated with, or funding from, probiotic companies [7].

Professional societies read this evidence differently:

• The American Gastroenterological Association (2020) suggests, as a conditional recommendation, specific formulations for adults and children taking antibiotics, including S. boulardii and certain two-, three- and four-strain combinations such as L. acidophilus CL1285 with L. casei LBC80R [9].
• The American College of Gastroenterology (2021) recommends against probiotics for preventing C. difficile in people taking antibiotics [10].
• A 2026 AGA expert review advises clinicians not to recommend probiotics for C. difficile prevention in people with inflammatory bowel disease [20].

There is also a biological question mark. In a study in mice and people, a multi-strain probiotic taken after antibiotics delayed, and left incomplete, the return of the gut's native microbial community compared with natural recovery [16]. That doesn't cancel out the diarrhea trials, but it is a reason not to take probiotics after every course of antibiotics by default.

IBS: a genuinely mixed picture

Irritable bowel syndrome is where guideline disagreement is most visible:

• The ACG (2021) suggests against probiotics for overall IBS symptoms, based on very low-quality evidence [11].
• The AGA (2020) recommends probiotics for IBS only in the context of a clinical trial [9].
• The British Society of Gastroenterology (2021) says probiotics as a group may help overall symptoms and abdominal pain, but no specific strain can be recommended. It considers it reasonable to try one for up to 12 weeks and stop if symptoms don't improve [12].

A meta-analysis of 53 trials in 5,545 people with IBS found that some combinations, species and strains appeared helpful, but concluded that which ones work remains largely unclear [13].

Pro tip: If you and your clinician decide to try a probiotic for IBS, change one thing at a time. Use a single product at its studied dose, keep a simple symptom diary, and stop after 12 weeks if nothing has improved [12].

Where the evidence is weak, absent or negative

Synbiotics, prebiotics and fermented foods

Synbiotics combine live microorganisms with a substrate the host's microbes can use. An ISAPP expert panel distinguishes "complementary" synbiotics, which pair a probiotic with a prebiotic, from "synergistic" synbiotics, in which the substrate is chosen specifically for the co-administered microbe [14]. The concept is appealing, but clinical evidence is thin: a 2023 European pediatric position paper found too little data to recommend for or against any of the synbiotic combinations it evaluated for the conditions it reviewed [15], and IBS data on prebiotics and synbiotics remain sparse [13]. Prebiotic fibers can also increase gas and bloating in some people, so start with a low dose if you try one.

Fermented foods such as yogurt, kefir, kimchi and sauerkraut are a food-first option. In a 17-week randomized study with 18 healthy adults per group, a diet high in fermented foods increased gut microbiome diversity and lowered markers of inflammation [19]. That is an encouraging but small study, and it didn't measure disease outcomes.

Who should avoid probiotics or ask first

For most healthy people, probiotics are unlikely to cause harm, and side effects are usually minor, such as gas [1]. Serious problems are rare but real, and they cluster in vulnerable groups:

• Critically ill and immunocompromised people. Probiotics have been linked to bloodstream bacterial and fungal infections, mostly in people who were severely ill or immunocompromised [1]. In one hospital's intensive care units, genome sequencing showed that Lactobacillus found in patients' blood matched the probiotic product they had been given [17]. At least 60 reports of fungemia (yeast in the blood) linked to probiotics containing Saccharomyces have been published since 1966, many involving patients in intensive care, on tube or intravenous feeding, with central venous catheters or on broad-spectrum antimicrobials [1].
• People with central venous catheters or structural heart disease. The ACG advises caution with probiotics in these groups and in immunocompromised patients [10].
• Preterm infants. In 2023 the FDA warned that probiotics given to hospitalized preterm infants can cause invasive, potentially fatal infections, citing one infant death that year and more than two dozen other adverse events reported since 2018 [18].

Safety note: If you are undergoing chemotherapy, have had a transplant, take immune-suppressing medicines, have a central line or a heart valve problem, or are caring for a premature baby, talk to your healthcare team before using any probiotic.

How to choose a quality probiotic product

Match the product to a specific goal first, then check the label:

Once you've chosen, give it a fair, time-limited trial. For IBS that means up to 12 weeks [12]; for antibiotic protection, start early and follow your clinician's advice on duration [1]. A few practical habits help:

• Test one product at a time. Stacking several probiotics makes it impossible to tell what, if anything, is working.
• Protect it from heat and humidity. Don't leave bottles in a hot car or a steamy bathroom, and respect the refrigeration instructions.
• Write down your starting point. A week of notes on stool pattern, bloating or pain before you begin makes it much easier to judge the result honestly.
• Tell your clinician and pharmacist. Include probiotics on your medication list, especially before surgery or a hospital stay.

The bottom line

Probiotics are not one supplement but many different strains, and the evidence is specific to the strain, the dose and the problem. The best-supported use is reducing antibiotic-associated diarrhea, particularly with S. boulardii or LGG; in children, doses of at least 5 billion CFU per day worked best. For C. difficile prevention and IBS, expert guidelines disagree, so any benefit is likely modest. There is no formal recommendation for healthy people to take a daily probiotic, and fermented foods are a reasonable alternative. People who are seriously ill, immunocompromised, have central lines, or are preterm infants should use probiotics only with medical guidance. When you buy one, insist on full strain names and CFUs guaranteed through the expiration date.